Abstract:<h3 class="Heading">Background</h3><p class="Para">Long non-coding RNA PTENP1, the pseudogene of PTEN tumor suppressor, has been reported to exert its tumor suppressive function via modulation of PTEN expression in many malignancies, including breast cancer (BC). However, whether the PTENP1/miR-20a/PTEN axis exists and how it functions in BC progression remains elusive.</p><h3 class="Heading">Methods</h3><p class="Para">The levels of PTENP1, PTEN and miR-20a were measured by qRT-PCR. Furthermore, the breast cancer cells proliferation was further measured by CCK8 assay, colony formation assays, EDU and Ki67 staining. The migratory and invasive ability was determined by transwell assay. Flow cytometry, JC-1 and TUNEL assays were conducted to show the occurrence of apoptosis. Xenograft model was used to show the tumorigenesis of breast cancer cells.</p><h3 class="Heading">Results</h3><p class="Para">We analyzed PTENP1 and PTEN levels in clinical BC samples and cell lines, and found that PTENP1 and PTEN were confirmed and closely correlated with the malignancy of BC cell lines and poor clinical prognosis. Moreover, alteration of PTENP1 affects BC cell proliferation, invasion, tumorigenesis and chemoresistance to adriamycin (ADR). Bioinformatic analysis and dual-luciferase reporter gene assay predicted that PTENP1 was a direct target of miR-20a, which was clarified an alternative effect on BC aggressiveness phenotype. In addition, PTENP1 functioned as an endogenous sponge of miR-20a to regulate PTEN expression, which mediated BC cells proliferation, invasion and drug resistance via activation the phosphatidylinositol-3 kinase (PI3K)/AKT pathway. PI3K inhibitor LY294002 or siAkt also prevented BC cells progression.</p><h3 class="Heading">Conclusion</h3><p class="Para">Collectively, these data indicated that PTENP1/miR-20a/PTEN axis involved in the malignant behaviors of BC cells, illuminating the possible mechanism mediated by PTEN via PI3K/Akt pathway. Targeting PTENP1/miR-20a/PTEN may provide a potential diagnosis and treatment strategy for BC.</p>

Phosphatase and Tensin Homolog (PTEN) Represses Colon Cancer Progression Through Inhibiting Paxillin Transcription Via PI3K/AKT/NF-κB Pathway*

Long Noncoding RNA Linc02023 Regulates PTEN Stability and Suppresses Tumorigenesis of Colorectal Cancer in a PTEN-dependent Pathway.

Regulation of paxillin-p130-PI3K-AKT signaling axis by Src and PTPRT impacts colon tumorigenesis

Regulation of the tumor suppressor PTEN by natural anticancer compounds

The regulation of PTEN: Novel insights into functions as cancer biomarkers and therapeutic targets

circPTEN suppresses colorectal cancer progression through regulating PTEN/AKT pathway

Identification And Functional Characterization Of Paxillin As A Target Of Protein Tyrosine Phosphatase Receptor T

Microrna-187 Inhibits Pten Expression And Promotes Cell Proliferation In Non-Small-Cell Lung Cancer

Effects of PTEN on the proliferation and apoptosis of colorectal cancer cells via the phosphoinositol-3-kinase/Akt pathway

Paxillin Knockdown Suppresses Metastasis and Epithelial‑mesenchymal Transition in Colorectal Cancer Via the ERK Signalling Pathway

KLF5-mediated COX2 upregulation contributes to tumorigenesis driven by PTEN deficiency

PTENP1/miR-20a/PTEN axis contributes to breast cancer progression by regulating PTEN via PI3K/AKT pathway

Tumor suppressor LHPP regulates the proliferation of colorectal cancer cells via the PI3K/AKT pathway.

PTEN in Colorectal Cancer: Shedding Light on Its Role as Predictor and Target

PTEN decreases NR2F1 expression to inhibit ciliogenesis during EGFR L858R -induced lung cancer progression

PTEN Inhibits the Migration and Invasion of HepG2 Cells by Coordinately Decreasing MMP Expression Via the PI3K/Akt Pathway

Decoding PTEN: from biological functions to signaling pathways in tumors

Clinical significance of tumor suppressor PTEN in colorectal carcinoma

Phosphatase and Tensin Homolog in Non-neoplastic Digestive Disease: More Than Just Tumor Suppressor

Pten Modulates Cell Cycle Progression and Cell Survival by Regulating Phosphatidylinositol 3,4,5,-Trisphosphate and Akt Protein Kinase B Signaling Pathway

The PTEN Conundrum: How to Target PTEN-Deficient Prostate Cancer